Searched for
NASAL COVID VACCINES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Worried about recent rise in COVID-19 cases? Here's how to protect yourself without getting a jabAmidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer and more target...
- Bharat Biotech's nasal Covid vaccine iNCOVACC launchedThe announcement regarding the launch of iNCOVACC on January 26 was made last week by the company’s chairman and managing director. The nas...
- On January 26, India's first COVID intranasal vaccination iNCOVACC will go on saleiNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...
- A nose for wider booster vaccinationThe development of the first nasal Covid vaccine, along with others before it, is an affirmation of India's capacity to provide solutions t...
- What you need to know about getting Bharat Biotech's nasal vaccine iNCOVACCBharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....
- Covid Nasal Vaccine: Here is how to book an appointment for a booster dose on CoWINThe Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...
- Covid-19 nasal vaccine is here: Price, benefits, all you need to knowBharat Biotech has finally announced the price of its intra nasal vaccine for Covid-19, the first in the world. Here is the price of Bharat...
- Bharat Biotech’s Covid-19 nasal vaccination now available on CoWIN app; Know how can you get itA heterologous booster dose of the nasal vaccination can be given to those who have already received Covishield and Covaxin.
- Easy to use, effective & economical: Nasal Covid vaccines to be a game-changer, say scientistsResearchers believe mucosal vaccines may prevent even mild cases of illness and block transmission to other people.
- Easy to use, more effective and cheap, nasal Covid vaccines can be game changer: scientistsEarlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approva...
- Inhaled vaccine for COVID-19: The pandemic-accelerated research for jab-free vaccine now in human testingA friendlier way to take a vaccine, the inhaled form requires much less vaccine - as little as one per cent of what is currently being used...
- No more jabs: Nasal Covid vaccines may be the future as they treat the infection right where it startsNasal vaccines are administered, as the name suggests, through the nose.
- The answer to stopping the coronavirus may be up the noseThe currently available Covid-19 vaccines are injected into people’s arm muscles and are highly capable at combating the virus once people ...
- DCGI allows Bharat Biotech to conduct phase-3 trials for Covid's intranasal booster doseThe trials of the Intranasal vaccine will take place at nine different sites of the country.
- Government panel recommends mixing Bharat Biotech's Covaxin and nasal vaccine in trialsThe subject expert committee (SEC) under India's drug regulator gave its go-ahead to Hyderabad-based Bharat Biotech to conduct the phase 2/...
- Subject expert committee nod to Bharat Biotech’s intranasal vaccine trialsThe company had sought permission to conduct both phase-I and phase-II trials. “However, the SEC has asked the company to present data of p...
- Drug regulator may meet this week to consider Sputnik trialsDr Reddy’s had in September entered into a partnership with Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V –...
- Bharat Bio seeks nod to conduct trials of nasal Covid vaccineBharat Biotech, which has developed India’s indigenous Covid-19 vaccine, Covaxin, has sought regulatory approval to start phase-1 and phase...
Load More
